Antiviral agents

Dermatologic Clinics

Volumn 19, Issue 1, 2001, Pages 23-34

  Brown, Tricia J ^a   Vander Straten, Melody ^b   Tyring, Stephen K ^b  

^a Dermatology

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; ADEFOVIR; ADEFOVIR DIPIVOXIL; AMPRENAVIR; CIDOFOVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FAMCICLOVIR; FOMIVIRSEN; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PENCICLOVIR; PROTEINASE INHIBITOR; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TRIFLURIDINE; VALACICLOVIR; VIDARABINE; ZALCITABINE; ZIDOVUDINE;

CYTOMEGALOVIRUS; HERPES LABIALIS; HERPES SIMPLEX VIRUS; PRIORITY JOURNAL; REVIEW; VARICELLA ZOSTER VIRUS; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0035162069     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70227-8     Document Type: Article

References (82)

1. Images in clinical medicine: Buffalo hump in a patient with the acquired immunodeficiency syndrome
2. Antiviral drugs
3. Prostaglandin E plus famciclovir: A new concept for the treatment of severe hepatitis B after liver transplantation
4. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)-guanine (BRL 39123) in cell culture
5. Penciclovir: A review of the spectrum of activity, selectivity, and cross-resistance pattern
6. Practical management of patients treated with alpha interferon
7. Images in clinical medicine: Lipodystrophy associated with an HIV-protease inhibitor
8. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
9. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
10. Developments in the antiviral treatment of genital herpes
11. Survey of resistance of herpes simplex virus to acyclovir in northwest England
12. Mechanism of action of foscarnet against viral polymerases
13. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir
14. Nevirapine, zidovudine and didanosine in patients with HIV-1 infection: A randomized, double-blind, placebo-controlled trial
15. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group
16. The HIV-1 protease as a therapeutic target for AIDS
17. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: A randomized, double-blind, placebo-controlled trial
18. A preliminary trial of lamivudine for chronic hepatitis B infection
19. Extended lamivudine retreatment for chronic hepatitis B
20. Lamivudine as initial treatment for chronic hepatitis B in the United States
21. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues
22. Interferon-alpha in malignant and viral diseases: A review
23. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus
24. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine
25. Herpes simplex resistance to acyclovir: A study in a tertiary care centre
26. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
27. Foscarnet-induced penile ulcer
28. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome
29. A penile ulceration in a patient with the acquired immunodeficiency syndrome: Foscarnet-induced penile ulceration
30. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase
31. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: Results from a randomized, controlled clinical trial
32. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation
33. Foscarnet-induced penile ulcer in an uncircumcised patient with AIDS
34. Nonhepatic manifestations and combined diseases in HCV infection
35. Famciclovir therapy for recurrent hepatitis B infection after liver transplantation
36. Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir
37. High-dose nevirapine: Safety, pharmacokinetics, an antiviral effect in patients with human immunodeficiency virus infection
38. Loss of serum HBV DNA and HbeAg and seroconversion following short-term (12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: Two placebo-controlled phase II studies
39. The mode of action of penciclovir
40. Mode of action of 9-(4-hydroxy-3-hydroxy-methybutyl-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells
41. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation
42. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo controlled trial
43. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir
44. "Buffalo hump" in men with HIV-1 infection
45. A double-blind placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B infection
46. Human immunodeficiency virus type 1 protease inhibitors
47. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
48. Antiviral agents in dermatology: Current status and future prospects
49. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women
50. Penile ulceration with foscarnet therapy
51. HPMPC (cidofovir), PMEA (adefovir) and related acyclic-nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections
52. A six month dose ranging study of the safety and efficacy of lamivudine in chronic hepatitis B
53. Dermatologic disorders associated with viral hepatitis infections
54. Herpes simplex: Evolving concepts
55. Herpes simplex virus resistance to acyclovir: Clinical relevance
56. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group
57. Pharmacokinetics of famciclovir in man
58. HIV-1 protease inhibitor-associated partial lipodystrophy: Clinicopathologic review of 14 cases
59. Virostatika-Resistenz bei Herpesviren: Mechanismen, Haufigkeit und klinische Bedeutung
60. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
61. Clinical uses of cidofovir
62. Safety of famciclovir in patients with herpes zoster and genital herpes
63. The skin-liver connection
64. Durability of HbeAg seroconversion after lamivudine monotherapy in controlled phase II and III trials
65. Foscarnet-induced penile ulceration
66. The effect of protease inhibitors on weight and body composition in HIV-infected patients
67. Pretransplant famciclovir for prophylaxis for hepatitis B virus recurrence after liver transplantation
68. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster
69. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans
70. 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase
71. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
72. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells
73. Three new drugs for HIV infection
74. Efficacy of famciclovir in chronic hepatitis B: Results of a dose finding study
75. Foscarnet and penile ulceration
76. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind test
77. Efficacy and safety of oral lobucavir (LBV) in patients with recurrent genital herpes
78. Protease inhibitor-induced lipodystrophy
79. Randomized comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients
80. Interferon alfa in the treatment of chronic viral hepatitis B and C
81. Antiviral therapy of herpes simplex and varicella-zoster virus infections
82. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation